Search results
Scientists in Missouri, Virginia receive pediatric heart transplantation research grants
NewMediaWire via Yahoo Finance· 3 days agoDALLAS, April 22, 2024 — Scientific researchers in Missouri and Virginia have been awarded nearly...
Immunovia announces updated financial calendar
WDTN-TV 2 Dayton· 3 days agoImmunovia (NASDAQ Stockholm: IMMNOV), the diagnostics company with the mission to increase pancreatic cancer survival rates through early detection, updates its financial calendar for 2024.
JD Supra: Patent Litigation Update 2024
JD Supra· 5 days agoWhile the number of filed patent cases is down, it is still the most prevalent type of IP claim. Of course, the vast majority of patent infringement actions (~97%) are settled. Likely due to ...
WSU professor warns of fire blight antibiotic resistance
The Columbian· 7 days agoFrank Zhao, a professor of plant pathology at Washington State University, spoke at the April 4 Fire Blight Webinar hosted by Michigan State University, providing an update ...
Charles River (CRL) to Report Q1 Earnings: Here's What to Expect
Zacks· 1 day agoFree Report) is scheduled to report first-quarter 2024 results on May 9, before market open. In the...
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business...
Digital Journal· 18 hours agoOrganizational redesign and rightsizing initiated across company to streamline structures, increase efficiency and reduce operating costsTogether with GSK, ended Pandemic Preparedness Agreement ...
New method safely recruits immune cells to fight cancer
Futurity· 2 days agoResearchers have developed a new cancer immunotherapy to localize cancer-killing cytokines in tumors to improve treatment effectiveness. Cancer is the monster of our society. Last year alone ...
Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III NSCLC
Journal of the American Medical Association· 3 days agoThis cohort study evaluates the characteristics, treatment patterns, and outcomes of patients with unresectable stage III non–small cell lung cancer who did or did not receive durvalumab.
Small Business - The Selma Times‑Journal | The Selma Times‑Journal
The Selma Times-Journal· 7 days agoTG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing ...
Derek C. Simmons
Fandom· 1 day agoDerek C. Simmons was born into a historically important family with a secret past. An ancestor of the Simmons line had been a founder of a mysterious organization known only as The Family,[& ...
